Research suggests that chromobox protein homolog 7 (CBX7) may play a role in suppressing certain cancerous characteristics in cells. The protein has been found to regulate various signaling pathways, including the myosin heavy chain 9-NF-κB pathway in glioblastoma cells, and may also affect other types of cancer, such as breast and hepatocellular carcinoma. The exact mechanisms and effects of CBX7 in different cancers are still being studied, with some research indicating that it can inhibit cell migration and tumorigenicity, while other studies explore its relationship to epigenetic regulation and patient survival.